Literature DB >> 12424194

Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesis.

W Beau Mitchell1, Ji Hong Li, Fiza Singh, Alan D Michelson, James Bussel, Barry S Coller, Deborah L French.   

Abstract

The recently published crystal structure of the external domains of alphaVbeta3 confirms the prediction that the aminoterminal portion of alphaV, which shares 40% homology with alphaIIb, folds into a beta-propeller structure and that the 4 calcium-binding domains are positioned on the bottom of the propeller. To gain insight into the role of the calcium-binding domains in alphaIIb biogenesis, we characterized mutations in the second and third calcium-binding domains of alphaIIb in 2 patients with Glanzmann thrombasthenia. One patient inherited a Val298Phe mutation in the second domain, and the other patient inherited an Ile374Thr mutation in the third domain. Mammalian cell expression studies were performed with normal and mutant alphaIIb and beta3 cDNA constructs. By flow cytometry, expression of alphaIIb Val298Phe/beta3 in transfected cells was 28% of control, and expression of alphaIIbIle374Thr/beta3 was 11% of control. Pulse-chase analyses showed that both mutant pro-alphaIIb subunits are retained in the endoplasmic reticulum and degraded. Mutagenesis studies of the Val298 and Ile374 residues showed that these highly conserved, branch-chained hydrophobic residues are essential at these positions and that biogenesis and expression of alphaIIbbeta3 is dramatically affected by structural variations in these regions of the calcium-binding domains. Energy calculations derived from a new model of the alphaIIb beta-propeller indicate that these mutations interfere with calcium binding. These data suggest that the alphaIIb calcium-binding domains play a key structural role in the beta-propeller, and that the structural integrity of the calcium-binding domains is critical for integrin biogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424194     DOI: 10.1182/blood-2002-07-2266

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  The regulation of integrin function by divalent cations.

Authors:  Kun Zhang; JianFeng Chen
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation.

Authors:  W Beau Mitchell; Jihong Li; Marta Murcia; Nathalie Valentin; Peter J Newman; Barry S Coller
Journal:  Blood       Date:  2007-01-05       Impact factor: 22.113

3.  alphaIIbbeta3 biogenesis is controlled by engagement of alphaIIb in the calnexin cycle via the N15-linked glycan.

Authors:  W Beau Mitchell; JiHong Li; Deborah L French; Barry S Coller
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

4.  Three novel beta-propeller mutations causing Glanzmann thrombasthenia result in production of normally stable pro-alphaIIb, but variably impaired progression of pro-alphaIIbbeta3 from endoplasmic reticulum to Golgi.

Authors:  E J R Nelson; J Li; W B Mitchell; M Chandy; A Srivastava; B S Coller
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

5.  Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation.

Authors:  Andrea Artoni; JiHong Li; Beau Mitchell; Jian Ruan; Junichi Takagi; Timothy A Springer; Deborah L French; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

6.  Mutations in and near the second calcium-binding domain of integrin alphaIIb affect the structure and function of integrin alphaIIbbeta3.

Authors:  Susan Gidwitz; Brenda Temple; Gilbert C White
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 7.  Glanzmann thrombasthenia: state of the art and future directions.

Authors:  Alan T Nurden; Xavier Pillois; David A Wilcox
Journal:  Semin Thromb Hemost       Date:  2013-08-08       Impact factor: 4.180

8.  Mutations in the Drosophila alphaPS2 integrin subunit uncover new features of adhesion site assembly.

Authors:  Danelle Devenport; Thomas A Bunch; James W Bloor; Danny L Brower; Nicholas H Brown
Journal:  Dev Biol       Date:  2007-04-12       Impact factor: 3.582

9.  Glanzmann thrombasthenia associated with a 21-amino acid deletion (Leu817-Gln837) in glycoprotein IIb due to abnormal splicing in exon 25.

Authors:  Tetsuro-Takahiro Fujimoto; Mihoko Sora; Kazuko Ide; Miyoko Mizushima; Masashi Mita; Shinichiro Nishimura; Kazuhiro Ueda; Kingo Fujimura
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 10.  Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?

Authors:  Alan Nurden
Journal:  J Blood Med       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.